Ipilimumab +/- Vaccine Therapy in Treating Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer

Clinical Trial ID NCT00836407

PubWeight™ 12.74‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00836407

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Evaluation of ipilimumab in combination with allogeneic pancreatic tumor cells transfected with a GM-CSF gene in previously treated pancreatic cancer. J Immunother 2013 2.80
2 Potential targets for pancreatic cancer immunotherapeutics. Immunotherapy 2011 1.29
3 CTLA-4 blockade increases antigen-specific CD8(+) T cells in prevaccinated patients with melanoma: three cases. Cancer Immunol Immunother 2011 1.10
4 Therapeutic cancer vaccines: past, present, and future. Adv Cancer Res 2013 0.99
5 Trial Watch: Immunostimulatory cytokines. Oncoimmunology 2013 0.96
6 Immune checkpoint blockade in cancer treatment: a double-edged sword cross-targeting the host as an "innocent bystander". Toxins (Basel) 2014 0.92
7 IP-10/CXCL10 attracts regulatory T cells: Implication for pancreatic cancer. Oncoimmunology 2015 0.87
8 Blockade of cytotoxic T-lymphocyte antigen-4 as a new therapeutic approach for advanced melanoma. Expert Opin Pharmacother 2011 0.80
9 Development of thyroglobulin antibodies after GVAX immunotherapy is associated with prolonged survival. Int J Cancer 2014 0.80
10 Modulation of CTLA-4 and GITR for cancer immunotherapy. Curr Top Microbiol Immunol 2011 0.80
11 Application of radiation technology in vaccines development. Clin Exp Vaccine Res 2015 0.78
12 Next-generation cancer vaccine approaches: integrating lessons learned from current successes with promising biotechnologic advances. J Natl Compr Canc Netw 2013 0.77
Next 100